Effects of Helicobacter pylori Infection on gastric mucin expression

Hyung Min Kang1, Nayoung Kim, Young Soo Park

  • 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea.

Abstract

Insights

Helicobacter pylori infection significantly reduces MUC6 expression in the stomach, particularly in cases of precancerous lesions. Eradicating H. pylori restores MUC6 levels, suggesting a role in gastric disease development.

Area of Science:

  • Gastroenterology and Molecular Biology
  • Investigates the role of mucin glycoproteins in the pathogenesis of H. pylori-associated gastroduodenal diseases.

Background:

  • Mucins, such as MUC5AC and MUC6, are critical components of the gastric mucosal barrier.
  • Helicobacter pylori infection is a major risk factor for various gastroduodenal pathologies, including ulcers, atrophic gastritis, and gastric cancer.

Purpose of the Study:

  • To determine the gastric distribution of MUC5AC and MUC6 in relation to H. pylori infection status.
  • To evaluate changes in MUC5AC and MUC6 expression in H. pylori-associated gastroduodenal diseases.
  • To assess the impact of H. pylori eradication on MUC5AC and MUC6 expression.

Main Methods:

  • Immunohistochemical staining was used to assess MUC5AC and MUC6 expression in gastric biopsies from 224 individuals (H. pylori-positive and negative).
  • Patients were categorized into control, duodenal ulcer, benign gastric ulcer, and dysplasia plus stomach cancer groups.
  • Expression levels were re-evaluated in a subset of H. pylori-positive patients after successful eradication therapy.

Main Results:

  • MUC6 expression was significantly lower in H. pylori-positive individuals compared to H. pylori-negative individuals, particularly in the gastric body.
  • MUC5AC and MUC6 expression were notably reduced in H. pylori-positive patients with dysplasia plus cancer and atrophic gastritis with intestinal metaplasia.
  • Aberrant MUC6 expression in foveolar cells was observed in H. pylori-positive individuals but normalized after eradication.

Conclusions:

  • H. pylori infection induces significant alterations in gastric mucin expression, specifically a reduction in MUC6.
  • These mucin expression changes are closely linked to the development of gastric atrophy with intestinal metaplasia.
  • The findings suggest a potential role for H. pylori-induced mucin alterations in the process of gastric carcinogenesis.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...